ES496426A0 - Un procedimiento para la preparacion de un adn que codifica un polipeptido con actividad de interferon. - Google Patents

Un procedimiento para la preparacion de un adn que codifica un polipeptido con actividad de interferon.

Info

Publication number
ES496426A0
ES496426A0 ES496426A ES496426A ES496426A0 ES 496426 A0 ES496426 A0 ES 496426A0 ES 496426 A ES496426 A ES 496426A ES 496426 A ES496426 A ES 496426A ES 496426 A0 ES496426 A0 ES 496426A0
Authority
ES
Spain
Prior art keywords
polipeptide
dna
codes
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES496426A
Other languages
English (en)
Other versions
ES8203102A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japanese Foundation for Cancer Research
Original Assignee
Japanese Foundation for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP13928979A external-priority patent/JPS5663996A/ja
Priority claimed from JP3393180A external-priority patent/JPS56131598A/ja
Application filed by Japanese Foundation for Cancer Research filed Critical Japanese Foundation for Cancer Research
Publication of ES8203102A1 publication Critical patent/ES8203102A1/es
Publication of ES496426A0 publication Critical patent/ES496426A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
ES496426A 1979-10-30 1980-10-30 Un procedimiento para la preparacion de un adn que codifica un polipeptido con actividad de interferon. Granted ES496426A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13928979A JPS5663996A (en) 1979-10-30 1979-10-30 Novel recombinant having gene complementary to human interferon messenger rna
JP3393180A JPS56131598A (en) 1980-03-19 1980-03-19 Novel recombinant plasmid having gene of human fibroblastic interferon messenger rna

Publications (2)

Publication Number Publication Date
ES8203102A1 ES8203102A1 (es) 1982-02-16
ES496426A0 true ES496426A0 (es) 1982-02-16

Family

ID=26372701

Family Applications (3)

Application Number Title Priority Date Filing Date
ES496426A Granted ES496426A0 (es) 1979-10-30 1980-10-30 Un procedimiento para la preparacion de un adn que codifica un polipeptido con actividad de interferon.
ES507595A Granted ES507595A0 (es) 1979-10-30 1981-11-30 Un procedimiento para la produccion de un plasmido recombi- nante.
ES507596A Expired ES8303530A1 (es) 1979-10-30 1981-11-30 Un procedimiento para la preparacion de un microorganismo que contiene un plasmido recombinante de un adn

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES507595A Granted ES507595A0 (es) 1979-10-30 1981-11-30 Un procedimiento para la produccion de un plasmido recombi- nante.
ES507596A Expired ES8303530A1 (es) 1979-10-30 1981-11-30 Un procedimiento para la preparacion de un microorganismo que contiene un plasmido recombinante de un adn

Country Status (8)

Country Link
EP (1) EP0028033B1 (es)
AU (1) AU538665B2 (es)
CA (1) CA1341563C (es)
DE (1) DE3071435D1 (es)
DK (1) DK458480A (es)
ES (3) ES496426A0 (es)
IL (1) IL61366A (es)
NO (1) NO158950C (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510472A (en) * 1979-11-21 1996-04-23 Yeda Research And Development Co. Ltd. Production of recombinant human interferon-beta2
US5554513A (en) * 1979-11-21 1996-09-10 Yeda Research & Development Co. Ltd. Production of recombinant human interferon-beta2
US6835557B1 (en) 1980-01-08 2004-12-28 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
PT72322B (en) * 1980-01-08 1982-09-23 Biogen Nv Process for preparation of recombinant dna molecules and of polipeptides similar to human interferon
DK33181A (da) * 1980-02-06 1981-08-07 Searle & Co Fremgangsmaade til fremstilling af et interferonlignende protein
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
PT72786B (en) * 1980-04-03 1983-01-10 Biogen Nv Process for producing dna sequences recombinant dna molecules and human fibroplast interferon-like polypeptides
NZ198445A (en) * 1980-09-25 1984-05-31 Genentech Inc Production of human fibroblast interferon by recombinant dna technology
DE3280127D1 (de) * 1981-03-27 1990-04-12 Ici Plc Genetisch modifizierte mikroorganismen.
IL65475A0 (en) * 1981-04-17 1982-07-30 Meloy Lab Production of immune interferon and its mrna
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
US4450103A (en) * 1982-03-01 1984-05-22 Cetus Corporation Process for recovering human IFN-β from a transformed microorganism
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4737462A (en) * 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
EP0242329B1 (en) 1986-04-15 1995-07-19 Ciba-Geigy Ag Monoclonal antibodies against interferon-induced human protein in pure form, and test kits containing these antibodies
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
GB9506051D0 (en) 1995-03-24 1995-05-10 Univ Singapore Gene expression
EP1426058A3 (de) 1997-09-23 2004-07-28 Dr. Rentschler Biotechnologie GmbH Flüssige Interferon-Beta Formulierungen
EP1276849A4 (en) 2000-04-12 2004-06-09 Human Genome Sciences Inc ALBUMIN FUSION PROTEINS
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
EP2277889B1 (en) 2001-12-21 2014-07-09 Human Genome Sciences, Inc. Fusion proteins of albumin and interferon beta
PT3321359T (pt) 2005-04-11 2021-03-11 Horizon Pharma Rheumatology Llc Formas variantes de urato-oxidase e a sua utilização
US9534013B2 (en) 2006-04-12 2017-01-03 Horizon Pharma Rheumatology Llc Purification of proteins with cationic surfactant
EP2207890A4 (en) 2007-10-05 2010-12-15 Barofold Inc HIGH PRESSURE PROCESSING OF AGGREGATED INTERFERONS
SG10201408480RA (en) 2009-06-25 2015-02-27 Crealta Pharmaceuticals Llc Methods for preventing or predicting infusion reactions or antibody-mediated loss of response, by monitoring serum uric acid levels during pegylated uricase therapy
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Also Published As

Publication number Publication date
EP0028033A3 (en) 1981-08-19
ES8303529A1 (es) 1983-02-01
NO158950C (no) 1988-11-16
AU6376280A (en) 1981-05-07
ES8203102A1 (es) 1982-02-16
DE3071435D1 (en) 1986-03-27
IL61366A (en) 1983-11-30
CA1341563C (en) 2007-12-04
NO803230L (no) 1981-05-04
IL61366A0 (en) 1980-12-31
ES507596A0 (es) 1983-02-01
ES507595A0 (es) 1983-02-01
EP0028033B1 (en) 1986-02-19
AU538665B2 (en) 1984-08-23
EP0028033A2 (en) 1981-05-06
DK458480A (da) 1981-05-01
ES8303530A1 (es) 1983-02-01
NO158950B (no) 1988-08-08

Similar Documents

Publication Publication Date Title
ES496426A0 (es) Un procedimiento para la preparacion de un adn que codifica un polipeptido con actividad de interferon.
ES487852A0 (es) Un procedimiento para la preparacion de interferon tipo ii.
ES528628A0 (es) Un procedimiento para la preparacion de pirazolo y piridazo-pirazolinas, piridazinas y diazepinas.
ES504291A0 (es) Un procedimiento para la preparacion de benzotio-en y benzofuransulfonamidas.
ES545464A0 (es) Un procedimiento para la preparacion de tetrahidroftalimidas.
ES540705A0 (es) Un procedimiento para la preparacion de 17b-carbamoil-n-monosustituido -o 17b-acil-4-aza-5-alfa-androstien-3-onas.
ES501645A0 (es) Un procedimiento para la preparacion de 6-alquiliden-penamas.
ES506969A0 (es) Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES505464A0 (es) Un procedimiento para la preparacion de n-heterociclilaminocarbonil arilsulfonamidas.
ES494131A0 (es) Un procedimiento para la preparacion de diariltiofenos.
ES507287A0 (es) Un procedimiento para la preparacion de catalizadores de o- xidacion.
ES540609A0 (es) Un procedimiento para la preparacion de pirazolo piridinas.
ES491944A0 (es) Un procedimiento para la preparacion de tienamicinas.
ES540610A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES544521A0 (es) Un procedimiento para la preparacion de triazolobenzodiazefinas.
ES546872A0 (es) Un procedimiento para la preparacion de aminoalcoxibenzopiranonas.
ES507501A0 (es) Un procedimiento para la preparacion de imidazolilfenilamidinas.
ES503307A0 (es) Un procedimiento para la preparacion de quinoxaliniloxieteres.
ES491835A0 (es) Un procedimiento para la preparacion de mono-y-di-esteres desacarosa.
ES515157A0 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES503172A0 (es) Un procedimiento para la preparacion de benzamidas.
ES503169A0 (es) Un procedimiento para la preparacion de tiofen-sulfonamidas con actividad insecticida.
ES498945A0 (es) Un procedimiento para la preparacion de benzamidas.
ES490277A0 (es) Un procedimiento para la preparacion de aminoeteres.
ES512026A0 (es) Un procedimiento para la preparacion de ranitidina.